Phase 4 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with classical Hodgkin lymphoma (a specific type of blood cancer), confirmed by laboratory testing of tissue.
- People whose kidneys, liver, lungs, and general body chemistry are functioning within normal ranges.
- People (or their legal guardians, if applicable) who have read and signed a consent form agreeing to take part.
Who may not be able to join:
- People whose diagnosis is a specific subtype called nodular lymphocyte predominant Hodgkin lymphoma, rather than classical Hodgkin lymphoma.
- People who had any form of weakened immune system before their diagnosis, including inherited immune conditions, being a transplant recipient, or having taken any immune-suppressing medications (including steroid medications) in the 28 days before diagnosis.
- People who are pregnant or breastfeeding at the time of the trial.
- Female patients who are sexually active and do not agree to use an effective form of contraception during treatment.
- People whose blood test shows a positive result for HIV.
- People who have a skin condition called pemphigus or a liver condition called hepatic ductopenia (confirm with trial site).
- People whose Hodgkin lymphoma developed as a result of, or alongside, another cancer.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +541131207433
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Event-free Survival; Overall Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.